Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directions

The new Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) triggered the pandemic of COVID-19, which is currently still ongoing. In 2021 a worldwide vaccine campaign was launched, and in parallel the lines of research are continuing to target the most effective drug therapies for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitiello, Antonio, Zovi, Andrea, Trama, Ugo, Ferrara, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638345/
https://www.ncbi.nlm.nih.gov/pubmed/36331568
http://dx.doi.org/10.1007/s00059-022-05142-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638345/
https://www.ncbi.nlm.nih.gov/pubmed/36331568
http://dx.doi.org/10.1007/s00059-022-05142-6

Ejemplares similares